1. Home
  2. AGYS vs IDYA Comparison

AGYS vs IDYA Comparison

Compare AGYS & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilysys Inc.

AGYS

Agilysys Inc.

HOLD

Current Price

$114.61

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$41.58

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGYS
IDYA
Founded
1963
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.6B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
AGYS
IDYA
Price
$114.61
$41.58
Analyst Decision
Buy
Strong Buy
Analyst Count
4
16
Target Price
$111.67
$52.86
AVG Volume (30 Days)
277.3K
701.7K
Earning Date
05-18-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
67.07
61.90
EPS
0.32
N/A
Revenue
$319,312,000.00
$218,710,000.00
Revenue This Year
$17.65
N/A
Revenue Next Year
$14.36
$201.05
P/E Ratio
$357.81
N/A
Revenue Growth
15.85
3024.43
52 Week Low
$61.50
$23.23
52 Week High
$144.82
$42.68

Technical Indicators

Market Signals
Indicator
AGYS
IDYA
Relative Strength Index (RSI) 56.74 73.09
Support Level $112.83 $33.23
Resistance Level $114.23 N/A
Average True Range (ATR) 3.83 1.25
MACD -0.07 0.51
Stochastic Oscillator 70.94 89.03

Price Performance

Historical Comparison
AGYS
IDYA

About AGYS Agilysys Inc.

Agilysys Inc is engaged in hospitality software, delivering cloud-native SaaS and on-premise solutions for hotels, multi-amenity resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It operates across the Americas, Europe, the Middle East, Africa, Asia-Pacific, and India with headquarters located in Alpharetta, GA. The Company has one reportable segment serving the global hospitality industry.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: